23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Oehl, M. A.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Ogel, N.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Ohl, F.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Refinement of inbred mouse strains as animal models for psychiatric disorders
Influence of circadian factors on behavioral and cognitive testing in mice

Ometto, M.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Opgen-Rhein, C.

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

Ostermeier, C. P.

Subjective response to psychotropic drugs in psychiatric in-patients

Otte, C.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Ottomeyer, C.

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells